AUA Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
AUA Capital Management's IBB Position: Q1 2023 in Review
AUA Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 574 shares — an estimated $75.4K sold.
AUA Capital Management first reported a position in IBB in Q4 2016 and held it in 25 quarters. The position peaked at $182K in Q4 2016. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.
- AUA Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
- AUA Capital Management sold 574 iShares Biotechnology ETF shares in Q1 2023, an estimated $75.4K.
- AUA Capital Management first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 25 quarters.
- AUA Capital Management's iShares Biotechnology ETF position peaked at $182K in Q4 2016.
- 866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.
Based on AUA Capital Management's 13F filing for Q1 2023, filed 20 Apr 2023.